Literature DB >> 23495458

Leveraging the military health system as a laboratory for health care reform.

Kevin A Dorrance1, Suneil Ramchandani, Nancy Neil, Harry Fisher.   

Abstract

The Patient Protection and Affordable Care Act recently passed into law is poised to profoundly affect the provision of medical care in the United States. In today's environment, the foundation for most ongoing comparative effectiveness research is financial claims data. However, there is an alternative that possesses much richer data. That alternative, uniquely positioned to serve as a test system for national health reform efforts, is the Department of Defense Military Health System. This article describes how to leverage the Military Health System and provide effective solutions to current health care reform challenges in the United States.

Entities:  

Mesh:

Year:  2013        PMID: 23495458     DOI: 10.7205/milmed-d-12-00168

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  6 in total

1.  Advanced Metrics for Assessing Holistic Care: The "Epidaurus 2" Project.

Authors:  Frederick O Foote; Herbert Benson; Ann Berger; Brian Berman; James DeLeo; Patricia A Deuster; David J Lary; Marni N Silverman; Esther M Sternberg
Journal:  Glob Adv Health Med       Date:  2018-02-20

2.  Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Cotransporter 2 Inhibitor: Results From the EASEL Population-Based Cohort Study (Evidence for Cardiovascular Outcomes With Sodium Glucose Cotransporter 2 Inhibitors in the Real World).

Authors:  Jacob A Udell; Zhong Yuan; Toni Rush; Nicholas M Sicignano; Michael Galitz; Norman Rosenthal
Journal:  Circulation       Date:  2017-11-13       Impact factor: 29.690

3.  Comparative safety and effectiveness of dabigatran vs. rivaroxaban and apixaban in patients with non-valvular atrial fibrillation: a retrospective study from a large healthcare system.

Authors:  Todd C Villines; Azhar Ahmad; Michaela Petrini; Wenbo Tang; Amber Evans; Toni Rush; David Thompson; Kelly Oh; Eric Schwartzman
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2019-04-01

4.  Systemic sclerosis medications and risk of scleroderma renal crisis.

Authors:  S M Gordon; J B Hughes; R Nee; R S Stitt; W T Bailey; D J Little; J D Edison; S W Olson
Journal:  BMC Nephrol       Date:  2019-07-25       Impact factor: 2.388

5.  Prevalence and Characteristics of CKD in the US Military Health System: A Retrospective Cohort Study.

Authors:  James D Oliver; Robert Nee; Lindsay R Grunwald; Amanda Banaag; Meda E Pavkov; Nilka Ríos Burrows; Tracey Pérez Koehlmoos; Eric S Marks
Journal:  Kidney Med       Date:  2022-05-23

6.  Incidence and characteristics of major bleeding among rivaroxaban users with renal disease and nonvalvular atrial fibrillation.

Authors:  Manesh R Patel; W Frank Peacock; Sally Tamayo; Nicholas Sicignano; Kathleen P Hopf; Zhong Yuan
Journal:  Clin Exp Emerg Med       Date:  2018-03-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.